Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells (Q38344688)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 April 2010

Language	Label	Description	Also known as
English	Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells	scientific article published on 20 April 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells (English)

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Y Tomimaru

1

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

H Eguchi

2

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

H Wada

3

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

T Noda

4

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

M Murakami

5

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

S Kobayashi

6

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

S Marubashi

7

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

Y Takeda

8

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

M Tanemura

9

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

K Umeshita

10

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

Y Doki

11

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

M Mori

12

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

H Nagano

13

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

language of work or name

0 references

publication date

20 April 2010

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

102

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

10

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

1483-1490

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Global changes in STAT target selection and transcription regulation upon interferon treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Characterization of cells with different mitochondrial membrane potential during apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

6 September 2017

Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

14 September 2017

Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

27 September 2017

Igf-independent regulation of breast cancer growth by IGF binding proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

23 June 2018

Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

31 August 2018

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

31 August 2018

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

31 August 2018

Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869168

31 August 2018

Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605669

21 January 2018

Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of interferon alpha/beta receptor in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pilot Study of Intrahepatic Arterial Chemotherapy with Methotrexate, 5-Fluorouracil, Cisplatin and Subcutaneous Interferon-Alpha-2b for Patients with Locally Advanced Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605669

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38344688&oldid=2201592047"